DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Evans M, Hicks D, Patel D. et al
Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes.
Diabetes Ther 2020;
11: 37-52
DOI: 10.1007/s13300-019-00728-6.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.